SCHEDULE 13D 1671957 XXXXXXXX LIVE Common Stock 03/17/2025 false 0001997403 00098936T ZenaTech, Inc.

777 HORNBY STREET, SUITE 600 VANCOUVER A1 V6Z 1S4

Dr. Shaun Passley (647) 249-1622 777 Hornby Street, Suite 600 Vancouver A1 V6Z 1S4 0001671957 Dr. Shaun Passley OO X1 25636459 120937093 25636459 120937093 120937093 89 IN Comprised of (i) 6,367,301 common shares, 11,700,000 preferred stock and 45,000 super-voting shares held by Epazz, Inc. ("Epazz"), (ii) 5,136,459 common shares, 3,500,000 preferred shares and 10,000 super-voting shares held by Dr. Passley, and (iii) 1,583,333 common shares, 750,000 preferred shares and 5,000 super-voting shares held by Ameritek Ventures Inc. ("Ameritek"). Each preferred share can convert to three shares of common stock. Each super-voting share carries 1,000 votes per share. The aggregate number of votes available at the Company, assuming the conversion of all preferred shares to common shares and the exercise of voting rights attached to such common shares and the exercise of voting rights attached to all super-voting shares, is 136,551,124. Dr. Passley is the sole director and officer of Epazz and is its principal shareholder with 95% voting control of Epazz, Inc. Dr. Passley is a director, officer, and principal shareholder of Ameritek of which Epazz is the principal shareholder with 95% voting control of Ameritek. Accordingly, Dr. Passley controls the voting rights attached to the shares of the Issuer owned by Epazz and Ameritek. 0001335239 Epazz Inc OO WY 0 86467301 0 86467301 112103760 82 CO Comprised of, (i) 6,367,301 common shares, 11,700,000 preferred stock and 45,000 super-voting shares held by Epazz, Inc. ("Epazz"), and (ii) 5,136,459 common shares, 3,500,000 preferred shares and 10,000 super-voting shares held by Dr. Passley. Each preferred share can convert to three shares of common stock. Each super-voting share carries 1,000 votes per share. The aggregate number of votes available at the Company, assuming the conversion of all preferred shares to common shares and the exercise of voting rights attached to such common shares and the exercise of voting rights attached to all super-voting shares, is 136,551,124. 0001530185 Ameritek Ventures, Inc. OO NV 0 34469792 0 34469792 34469792 25 CO Comprised of (i) 5,136,459 common shares, 3,500,000 preferred shares and 10,000 super-voting shares held by Dr. Passley, and (ii) 1,583,333 common shares, 750,000 preferred shares and 5,000 super-voting shares held by Ameritek Ventures Inc. ("Ameritek"). Each preferred share can convert to three shares of common stock. Each super-voting share carries 1,000 votes per share. The aggregate number of votes available at the Company, assuming the conversion of all preferred shares to common shares and the exercise of voting rights attached to such common shares and the exercise of voting rights attached to all super-voting shares, is 136,551,124. Common Stock ZenaTech, Inc. 777 HORNBY STREET, SUITE 600 VANCOUVER A1 V6Z 1S4 This Schedule 13D relates to the common shares, preferred shares and super-voting shares of ZenaTech Inc., a British Columbia, Canada corporation (the "Issuer"). The principal executive offices of the Issuer are located at Suite 600, 777 Hornby Street, Vancouver, British Columbia V6Z 1S4 Canada. Shaun Passley 777 Hornby Street, Suite 600 Vancouver, British Columbia Canada V6Z 1S4 (a) This statement on Schedule 13D is filed on behalf of Epazz, Inc. (Epazz), Ameritek Ventures, Inc. (Ameritek) and Dr. Shaun Passley (collectively the Reporting Persons) subsequent to receiving minority shareholder approval of the acquisition by the Company of certain assets from Epazz and Ameritek as described in the Information Circular relating to the Annual and Special Meeting of Shareholders of the Company (the Information Circular) held on March 17, 2025 (a copy of which was filed by the Company with the SEC under cover of Form 6-K dated February 27, 2025). Dr. Passley is the sole director and officer of Epazz, and is its principal shareholder with 95% voting control of Epazz. Dr. Passley is also the sole director, officer, and principal shareholder of Ameritek, as Epazz is the principal shareholder of Ameritek with 95% voting control of Ameritek. (b) Epazz is organized under the laws of the State of Wyoming and its business address is 55 E. Jackson Blvd. Chicago, IL 60604. Epazz is in the business of developing technology. Dr. Passley is a USA citizen and is the sole director and officer of Epazz. Ameritek is organized under the laws of the State of Nevada and its business address is 325 N Milwaukee Ave. Wheeling, IL 60090. Ameritek is in the business of technology solutions. Dr. Passley is the sole director and officer of Ameritek. Dr. Passley's principal occupation is the CEO of the Issuer. (c) See (b) above. (d) During the past five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). N/A U.S.A. The Reporting Persons were issued common shares, super-voting shares and/or preferred shares subsequent to receiving minority shareholder approval of the acquisition by the Company of certain assets from Epazz and Ameritek as described in the Information Circular. See Section 5(c) below for more information. The Reporting Persons acquired the Issuer's common stock for investment purposes. None of the Reporting Persons have any plans or proposals which relate to or would result in any of the matters listed in Items 4(a) to 4(j) of Schedule 13D. The beneficial holdings of Epazz, Ameritek and Dr. Passley in the Company are set forth under Section 5(c) below. Dr. Passley is the sole director and officer of Epazz, and is its principal shareholder with 95% voting control of Epazz. Dr. Passley is a director, officer, and principal shareholder of Ameritek of which Epazz, is the principal shareholder with 95% voting control of Ameritek. Accordingly, Dr. Passley controls the voting rights attached to the shares of the Issuer owned by Epazz and Ameritek. As described in the Information Circular, at the Company's Annual and Special Meeting held on March 17, 2025, the minority shareholders of the Company approved the acquisition of certain assets from Epazz and Ameritek pursuant to four purchase agreements. In consideration for the assets acquired, the Company issued common shares, super-voting shares and preferred shares to Dr. Passley, Epazz and Ameritek as described in exhibit B attached hereto. See Exhibit B. Not applicable. None. Exhibit A: Joint Filing Agreement. Exhibit B: List of Shareholders. Dr. Shaun Passley Shaun Passley 03/28/2025 Epazz Inc Shaun Passley 03/28/2025 Ameritek Ventures, Inc. Shaun Passley 03/28/2025